Recursion Pharmaceuticals, Inc. financial data

Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 S Rio Grande Street, Salt Lake City, Utah
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Recursion Pharmaceuticals, LLC (to 12/4/2015)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 494 % -2.63%
Debt-to-equity 38.8 % -17.6%
Return On Equity -79.5 % -35.5%
Return On Assets -57.3 % -43.6%
Operating Margin -797 % -44.7%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 281M shares +35.9%
Entity Public Float 930M USD -1.16%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 242M shares +20.2%
Weighted Average Number of Shares Outstanding, Diluted 242M shares +20.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 49.6M USD -0.7%
Research and Development Expense 281M USD +50.6%
General and Administrative Expense 123M USD +35.8%
Costs and Expenses 445M USD +36.9%
Operating Income (Loss) -395M USD -43.7%
Nonoperating Income (Expense) 15.1M USD +14.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -98.1M USD -27.8%
Income Tax Expense (Benefit) -5.36M USD
Net Income (Loss) Attributable to Parent -375M USD -44.2%
Earnings Per Share, Basic -1.65 USD/shares -20.4%
Earnings Per Share, Diluted -1.65 USD/shares -20.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 474M USD +16.9%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 43.7M USD +133%
Assets, Current 522M USD +21.2%
Property, Plant and Equipment, Net 83.6M USD -6.83%
Operating Lease, Right-of-Use Asset 44.1M USD +26.3%
Intangible Assets, Net (Excluding Goodwill) 38.2M USD -10.6%
Goodwill 52.1M USD -14%
Other Assets, Noncurrent 308K USD +180%
Assets 776M USD +16.4%
Accounts Payable, Current 3.76M USD +80.3%
Employee-related Liabilities, Current 13.1M USD -17.2%
Accrued Liabilities, Current 33.4M USD +1.61%
Contract with Customer, Liability, Current 32.2M USD -55.9%
Liabilities, Current 86.1M USD -24.5%
Long-term Debt and Lease Obligation 22.9M USD
Contract with Customer, Liability, Noncurrent 29.2M USD -10.1%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 50.2M USD +9.57%
Other Liabilities, Noncurrent 3M USD
Liabilities 191M USD -3.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.16B USD -48%
Stockholders' Equity Attributable to Parent 584M USD +24.6%
Liabilities and Equity 776M USD +16.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -102M USD -39.5%
Net Cash Provided by (Used in) Financing Activities 13.9M USD +623%
Net Cash Provided by (Used in) Investing Activities -6.65M USD -24.6%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 281M shares +35.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -95.3M USD -24.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 483M USD +15.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13K USD -7.14%
Deferred Tax Assets, Valuation Allowance 305M USD +82.7%
Deferred Tax Assets, Gross 320M USD +79.2%
Operating Lease, Liability 58.8M USD +15.2%
Depreciation 16.4M USD +20.6%
Payments to Acquire Property, Plant, and Equipment 6.65M USD +28.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -375M USD -44.3%
Lessee, Operating Lease, Liability, to be Paid 76M USD +9.3%
Property, Plant and Equipment, Gross 136M USD +6.84%
Operating Lease, Liability, Current 8.61M USD +64.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.5M USD +32.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.3M USD +33.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.2M USD -7.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.9M USD +34.7%
Deferred Tax Assets, Operating Loss Carryforwards 118M USD +31%
Unrecognized Tax Benefits 5.42M USD +96.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.2M USD +5.49%
Additional Paid in Capital 1.74B USD +39.2%
Amortization of Intangible Assets 14M USD +610%
Depreciation, Depletion and Amortization 7.38M USD +97.9%
Deferred Tax Assets, Net of Valuation Allowance 15.6M USD +30.6%
Share-based Payment Arrangement, Expense 63.5M USD +77.9%
Interest Expense 98K USD +63.3%